Syndax Announces Presentation at 42nd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Syndax Pharmaceuticals (Nasdaq: SNDX) will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024. The CEO, Michael A. Metzger, will discuss the company's innovative pipeline of cancer therapies. The event will be live webcasted and a replay will be available on the company's website.

WALTHAM, Mass., Jan. 2, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer of Syndax, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 5:15 p.m. PT/ 8:15 p.m. ET.

A live webcast of the fireside chat can be accessed from the Investor section of the Company's website at www.syndax.com, where a replay of the event will also be available for a limited time.

About Syndax

Syndax Pharmaceuticals is a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. Highlights of the Company's pipeline include revumenib, a highly selective inhibitor of the menin–KMT2A binding interaction, and axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor. For more information, please visit www.syndax.com or follow the Company on Twitter and LinkedIn.

Syndax Contact

Sharon Klahre
Syndax Pharmaceuticals, Inc.
sklahre@syndax.com
Tel 781.684.9827

SNDX-G

View original content:https://www.prnewswire.com/news-releases/syndax-announces-presentation-at-42nd-annual-jp-morgan-healthcare-conference-302024252.html

SOURCE Syndax Pharmaceuticals, Inc.

FAQ

When will Syndax Pharmaceuticals present at the 42nd Annual J.P. Morgan Healthcare Conference?

Syndax Pharmaceuticals will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 5:15 p.m. PT/ 8:15 p.m. ET.

Who will be presenting at the conference?

Michael A. Metzger, the Chief Executive Officer of Syndax Pharmaceuticals, will be presenting at the conference.

What is the focus of Syndax Pharmaceuticals' pipeline?

Syndax Pharmaceuticals is developing an innovative pipeline of cancer therapies.

Where can the live webcast of the event be accessed?

The live webcast of the event can be accessed from the Investor section of Syndax Pharmaceuticals' website at www.syndax.com.

Will a replay of the event be available?

Yes, a replay of the event will be available for a limited time on Syndax Pharmaceuticals' website.